CINECA IRIS Institutional Research Information System

TORREGROSSA, LIBORIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.971
AS - Asia 4.987
EU - Europa 4.212
SA - Sud America 797
Continente sconosciuto - Info sul continente non disponibili 387
AF - Africa 386
OC - Oceania 6
Totale 20.746
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.707
SG - Singapore 1.679
IT - Italia 1.408
CN - Cina 1.296
HK - Hong Kong 771
BR - Brasile 658
DE - Germania 651
SE - Svezia 598
VN - Vietnam 456
AT - Austria 298
GB - Regno Unito 283
BG - Bulgaria 208
FR - Francia 199
CI - Costa d'Avorio 168
FI - Finlandia 163
CA - Canada 153
IN - India 144
TR - Turchia 140
RU - Federazione Russa 124
JP - Giappone 123
SN - Senegal 78
BD - Bangladesh 60
KR - Corea 56
NL - Olanda 51
AR - Argentina 45
PL - Polonia 45
IQ - Iraq 43
MX - Messico 43
ZA - Sudafrica 38
MA - Marocco 36
PK - Pakistan 33
SA - Arabia Saudita 31
UA - Ucraina 30
ES - Italia 27
ID - Indonesia 26
NG - Nigeria 25
EC - Ecuador 23
VE - Venezuela 20
UZ - Uzbekistan 18
CZ - Repubblica Ceca 16
CH - Svizzera 15
CO - Colombia 15
BE - Belgio 14
EE - Estonia 14
IR - Iran 13
LT - Lituania 13
IE - Irlanda 12
JM - Giamaica 12
JO - Giordania 12
KE - Kenya 11
NP - Nepal 11
PH - Filippine 11
GR - Grecia 9
PE - Perù 9
PY - Paraguay 9
CL - Cile 8
DO - Repubblica Dominicana 8
HU - Ungheria 8
PA - Panama 8
TN - Tunisia 8
DZ - Algeria 7
MY - Malesia 7
TT - Trinidad e Tobago 7
TW - Taiwan 7
AU - Australia 6
AZ - Azerbaigian 6
EG - Egitto 6
EU - Europa 6
HN - Honduras 6
PS - Palestinian Territory 6
UY - Uruguay 6
AL - Albania 5
IL - Israele 5
KZ - Kazakistan 5
OM - Oman 5
CR - Costa Rica 4
GT - Guatemala 4
NI - Nicaragua 4
SV - El Salvador 4
BB - Barbados 3
BO - Bolivia 3
BY - Bielorussia 3
CY - Cipro 3
GD - Grenada 3
LK - Sri Lanka 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
DK - Danimarca 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
KG - Kirghizistan 2
LB - Libano 2
LV - Lettonia 2
MC - Monaco 2
MK - Macedonia 2
MT - Malta 2
PT - Portogallo 2
RS - Serbia 2
BH - Bahrain 1
Totale 20.344
Salva come PNG Salva come JPEG
Città #
Ashburn 1.212
Dallas 1.161
Singapore 953
San Jose 764
Hong Kong 757
Chandler 660
Fairfield 574
Santa Clara 558
Woodbridge 386
Milan 311
Shanghai 288
Houston 287
Seattle 277
New York 271
Vienna 265
Beijing 248
Ann Arbor 219
Los Angeles 218
Sofia 206
Wilmington 205
Cambridge 202
Abidjan 168
Boardman 159
Council Bluffs 150
Munich 147
Pisa 143
Ho Chi Minh City 136
Florence 125
Princeton 119
Serra 119
Tokyo 111
Lawrence 99
Lauterbourg 95
Frankfurt am Main 85
London 85
Medford 83
Hanoi 82
Dakar 78
Hefei 72
Rome 66
Turku 65
Ottawa 61
Buffalo 60
São Paulo 60
Istanbul 59
Helsinki 54
San Diego 52
Seoul 47
Redondo Beach 46
Bremen 40
Cascina 39
Nanjing 33
Dong Ket 32
Izmir 32
Orem 32
Des Moines 31
Atlanta 30
Chicago 29
Ogden 29
Warsaw 29
Vicopisano 28
Montreal 27
Poplar 26
Belo Horizonte 25
Phoenix 25
Columbus 24
Redmond 24
Brooklyn 23
Paris 23
Toronto 23
Johannesburg 22
Lagos 22
Rio de Janeiro 22
Düsseldorf 21
Boulder 20
Haiphong 20
Nuremberg 20
Amsterdam 19
Fuzhou 19
Lancaster 19
Brasília 18
Lucca 18
Manchester 18
Naples 18
Guangzhou 17
Hyderabad 17
Tashkent 17
Ankara 16
Casablanca 16
Chennai 16
Denver 16
Quanzhou 16
Baghdad 15
Dearborn 15
Zhengzhou 15
Norwalk 14
Washington 14
Bologna 13
Da Nang 13
Jacksonville 13
Totale 13.771
Salva come PNG Salva come JPEG
Nome #
LOW PREVALENCE OF THE SOMATIC M918T RET MUTATION IN MICRO-MEDULLARY THYROID CANCER. 280
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies 257
Changing Trend of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Cancer Treated with Total Thyroidectomy Without ¹³¹I Ablation 245
Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center 240
Lenvatinib Administered via Nasogastric Tube in Poorly Differentiated Thyroid Cancer 240
The presence of a tall cells>10% in a classical variant of papillary thyroid carcinoma (CV-PTC) makes its aggressiveness similar to that of tall cell variant (TCV-PTC) 234
A complex MEN2 syndrome, a mixture of 2B and 2A, associated with a new RET germiline deletion. 229
Incidental versus clinically evident thyroid cancer: A 5-year follow-up study 224
A proteomic profile of washing fluid from the colorectal tract to search for potential biomarkers of colon cancer. 220
Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: Clinical implications derived from the first prospective randomized controlled single institution study 220
Delayed 131-I First Treatment After Surgery has No Impact on the Median Term Outcome of Patients with Intermediate Risk Differentiated Thyroid Cancer 216
mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases 210
Lung recurrence of papillary thyroid cancer diagnosed with antithyroglobulin antibodies after 10 years from initial treatment. 206
The Italian Consensus for the Classification and Reporting of Thyroid Cytology: Cytohistologic and molecular correlations on 37,371 nodules from a single institution 206
Evaluation of formalin-fixed paraffin-embedded tissues in the proteomic analysis of parathyroid glands. 205
Cytological and Ultrasound Features of Thyroid Nodules Correlate with Histotypes and Variants of Thyroid Carcinoma 201
The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy 199
Correlation between the BRAF V600E Mutation and Tumor Invasiveness in Papillary Thyroid Carcinomas Smaller than 20 Millimeters: Analysis of 1060 Cases 193
Adipose tissue in COVID-19: detection of SARS-CoV-2 in adipocytes and activation of the interferon-alpha response 193
COVID-19 autopsy cases: detection of virus in endocrine tissues 192
Pre- And Post-Operative Circulating Tumoral Dna In Patients With Medullary Thyroid Carcinoma 191
Role Of Prophylactic Central Compartment Lymph Node Dissection On The Outcome Of Patients With Papillary Thyroid Carcinoma And Synchronous Ipsilateral Cervical Lymph Node Metastases 190
BRAF(K601E) Mutation in a Follicular Thyroid Adenoma 189
Fatal tracheal perforation following Dabrafenib-Trametinib therapy in BRAF V600E-mutant mixed anaplastic thyroid cancer 187
Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up 187
Clinical–Pathological Features and Treatment Outcome of Patients With Hobnail Variant Papillary Thyroid Carcinoma 185
Twenty years of lesson learning: How does the RET genetic screening test impact the clinical management of medullary thyroid cancer? 183
Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience 183
Potential impact of BMI on the aggressiveness of presentation and clinical outcome of Differentiated Thyroid Cancer 183
Exome analysis of a large family with Familial Isolated Primary Hyperparathyroidism (FIHP) and multiple cancers. 181
Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy 180
E-selectin expression and BRAF status in papillary thyroid carcinomas: Correlation with clinicopathologic features 179
BRAFV600E mutation is an indipendent predictive prognostic factor for persistent/recurrent disease in low risk differentiated Thyroid cancer patients: a 5 year follow-up study. 179
Thyroglobulin changes are highly dependent on TSH in low-risk DTC patients not treated with 131I 179
Fifty years after the first description, the MEN 2B syndrome diagnosisis still late: description of two recent cases 178
Role of the mononuclear cell infiltrate in Graves’ orbitopathy (GO): results of a large cohort study 177
Impact of energy-based devices in pediatric thyroid surgery 176
Activation of Type I and Type II Interferon Signaling in SARS-CoV-2-Positive Thyroid Tissue of Patients Dying from COVID-19 175
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer. 174
Central Neck Dissection Cannot Be Avoided In Medullary Thyroid Cancer (MTC) On The Basis Of Presurgical Serum Calcitonin (CT) 174
5 YEARS FOLLOW UP OF THYROGLOBULIN (TG), THYROGLOBULIN ANTIBODIES (TGAB) AND NECK ULTRASOUND (US) IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA (MPTC) TREATED WITH TOTAL THYROIDECTOMY BUT NOT ABLATED WITH 131I 173
Salvage total thyroidectomy for amiodarone-induced thyrotoxicosis in a SARS-CoV-2 positive patient: results of the viral genome research on the pathology sample of this destructive thyroiditis 171
MON-524 Prospective Evaluation of Patients with Encapsulated Classical Variant of Papillary Thyroid Cancer and Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Have They A Similar Prognosis? 170
Role of oxidative stress in radio-induced DNA damage and in RET/PTC rearrangement in papillary thyroid cancer 169
Identification of Two Different Phenotypes of Patients with Amiodarone-Induced Thyrotoxicosis and Positive Thyrotropin Receptor Antibody Tests 169
Down-regulation of miR-7-5p and miR-548ar-5p predicts malignancy in indeterminate thyroid nodules negative for BRAF and RAS mutations 169
Core Needle Biopsy Can Early and Precisely Identify Large Thyroid Masses 169
Differential expression of RET isoforms in normal thyroid tissues, papillary and medullary thyroid carcinomas 166
In Graves' disease, thyroid autoantibodies and ultrasound features correlate with distinctive histological features 165
DICER1 somatic mutations strongly impair miRNA processing even in benign thyroid lesions 165
GENETIC LANDSCAPE OF SOMATIC MUTATIONS IN A LARGE COHORT OF SPORADIC MEDULLARY THYROID CARCINOMAS STUDIED BY NEXT GENERATION TARGETED SEQUENCING 165
Chromosomal alterations in sporadic medullary thyroid carcinoma and correlation with outcome 164
CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas 164
Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas 163
Ponatinib (AP24534) is a novel potent inhibitor of oncogenic RET mutants associated with thyroid cancer 162
New insights in the molecular signature of advanced medullary thyroid cancer: Evidence of a bad outcome of cases with double RET mutations 162
Correction to: Whole exome sequencing in familial isolated primary hyperparathyroidism 162
null 160
null 159
Impact of Advanced Age on the Clinical Presentation and Outcome of Sporadic Medullary Thyroid Carcinoma 159
Histological pattern and gene expression profiling of thyroid tissue in subjects with obesity 159
Active surveillance in ret gene carriers belonging to families with multiple endocrine neoplasia 159
Metabolomics approach to thyroid nodules: A high-resolution magic-angle spinning nuclear magnetic resonance-based study 158
A large functioning parathyroid lipoadenoma 158
Clinical evolution of sporadic medullary thyroid carcinoma with biochemical incomplete response after initial treatment 157
Digital Gene Expression Analysis on Cytology Smears Can Rule Out Malignancy in Follicular-Patterned Thyroid Tumors 157
Clinical-Pathological and Molecular Evaluation of 451 NIFTP Patients from a Single Referral Center 157
An adrenal cortical adenoma with neuroendocrine-type granules mimicking pheochromocytoma 156
RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases 156
Body Mass Index and Sporadic Medullary Thyroid Cancer: Insights from a Large Series 155
Proteomic approach used in the diagnosis of Riedel's thyroiditis: a case report. 155
Papillary Thyroid Carcinoma With Rare exon 15 BRAF Mutation Has Indolent Behavior: A Single-Institution Experience 154
Expression of duox1 in papillary thyroid cancer and in normal thyroid tissues and correlation with ret/ptc rearrangements 154
5 Years Follow Up Of Thyroglobulin (Tg), Thyroglobulin Antibodies (Tgab) And Neck Ultrasound (Nus) In Patients With Papillary Thyroid Microcarcinoma (Mptc) Treated With Total Thyroidectomy But Not Ablated With 131I 152
Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysis 148
Long-Term Outcome of Patients with Low-Risk Differentiated Thyroid Cancer Treated with Total Thyroidectomy Alone 147
Whole Tumor Capsule Is Prognostic of Very Good Outcome in the Classical Variant of Papillary Thyroid Cancer 147
Do Patients with Atypical Parathyroid Adenoma Need Close Follow-up? 147
CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas. 145
Toward the Reliable Diagnosis of Indeterminate Thyroid Lesions: A HRMAS NMR-Based Metabolomics Case of Study 143
Anaplastic thyroid carcinoma: From clinicopathology to genetics and advanced therapies 143
Delayed radioiodine remnant ablation (RRA) does not impact on the outcome of intermediate risk for recurrence differentiated thyroid cancer patients (IR-DTC). 141
Human papillomavirus-related head and neck adenosquamous carcinoma: A systematic review and individual patient data meta-analysis 141
CXC Chemokine Receptor 4 Immunodetection in the Follicular Variant of Papillary Thyroid Carcinoma: Comparison to Galectin-3 and Hector Battifora Mesothelial Cell-1 139
Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas. 139
Gene expression profile in metastatic and non-metastatic parathyroid carcinoma 139
Molecular profiling of low-risk papillary thyroid carcinoma (mPTC) on active surveillance 136
Radioiodine remnant ablation (RRA) Impact on the dynamic risk of restratification in the short-term follow-up of patients with differentiated thyroid cancer (DTC). 135
Ret mutated C-cells proliferate more rapidly than non-mutated neoplastic cells 135
RET Copy Number Alteration in Medullary Thyroid Cancer Is a Rare Event Correlated with RET Somatic Mutations and High Allelic Frequency 133
High-intensity focused ultrasound as an alternative to the surgical approach in primary hyperparathyroidism: a preliminary experience 132
Galectin-3 is highly expressed in nonencapsutated papillary thyroid carcinoma but weakly expressed in encapsulated type; comparison with Hector Battifora mesothetial cell 1 immunoreactivity 131
The Usefulness of the International Grading System in the Management of Sporadic Medullary Thyroid Carcinoma 128
Minor role of TP53 and TERT promoter mutations in medullary thyroid carcinoma: report of new cases and revision of the literature 128
Correlation of the presurgical diagnosis of follicular variant of papillary thyroid cancer with the disease status after 10 years of follow-up. 128
First report of benign track seeding after robot-assisted transaxillary thyroid surgery 127
The Integrity of Tumor Capsule Identifies a Subgroup of Indolent Cases Not Only Among the Follicular (FVPTC) But Also in Classic Variant of Papillary Thyroid Cancer (CVPTC) 126
MicroRNA expression profiling of RAS-mutant thyroid tumors with follicular architecture: microRNA signatures to discriminate benign from malignant lesions 126
A Case of Unilateral Dermopathy Possibly Related to Graves' Disease 125
Atypical parathyroid adenomas: Challenging lesions in the differential diagnosis of endocrine tumors 125
Totale 17.067
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.711
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.711
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.179 0 24 41 48 198 223 58 42 74 63 104 304
2022/20232.376 227 351 197 200 250 260 29 192 473 11 152 34
2023/20241.487 117 132 192 169 177 264 76 37 29 39 108 147
2024/20254.614 46 146 63 263 453 452 376 206 461 530 502 1.116
2025/20266.835 443 897 949 702 701 437 957 302 339 672 222 214
2026/2027628 134 494 0 0 0 0 0 0 0 0 0 0
Totale 20.746